Dutch biotech CryoCloud raises €2M to enhance machine learning for drug discovery
The company’s platform enables researchers to visualise and analyse protein structures at high resolution, reducing the time and cost of molecular imaging. Dutch biotech CryoCloud has secured a €2M Seed funding round to expand its cryo-electron microscopy SaaS platform, which aims to streamline drug development by automating complex structural biology workflows. The round was led by Barcelona-based […]
Phlox Therapeutics Secures New Funding to Advance RNA Therapies for Genetic Cardiomyopathies
Phlox Therapeutics raises 1.9M funding to develop RNA therapies for genetic laminopathies The investor syndicate includes ROM Utrecht Region, FIRST Fund, Amsterdam-UMC Ventures and UHSF Funds support preclinical development of Phox’s lead program Naarden, The Netherlands, 6 November 2024 – Phlox Therapeutics, a private biotechnology company focused on developing innovative RNA-based therapies for cardiomyopathies, […]
LAUNCH UTRECHT HOLDINGS SEED FUND
Utrecht Holdings (Knowledge Transfer Office of the UU and the UMCU) introduces a new, 7,5-million-euro seed fund to invest in science-based startups, Utrecht Holdings Seed Fund.
Cordys Analytics Awarded Prestigious Eurostars Grant for AI-Powered Cardiovascular Diagnostics Project
Cordys Analytics is proud to announce that it has been awarded a prestigious Eurostars grant.
CryoCloud secures a 500k pre-seed investment to accelerate structure- based drug design with their cloud-native cryo-EM data analysis platform
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination.
